Clausen, M. R., Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J.
, Pedersen, R. S., Josefsson, P. L., Gørløv, J. S.
, Nørgaard, M. & d'Amore, F. (2020).
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
Hematological Oncology,
38(3), 318-325.
https://doi.org/10.1002/hon.2734
Christensen, M. S., Hansen, J.
, Ramlau-Hansen, C., Toft, G., d'Amore, F. & Kolstad, H. A. (2014).
0177 Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry.
Occupational & Environmental Medicine,
71 Suppl 1, A82-3.
https://doi.org/10.1136/oemed-2014-102362.257
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G.
, D'Amore, F. A. & Kolstad, H. (2014).
Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine,
71(Suppl 1).
Christensen, B., Ludvigsen, M., Nellemann, B., Kopchick, J. J.
, Honoré, B. & Jørgensen, J. O. L. (2015).
Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers.
PLoS One,
10(2), e0117119.
https://doi.org/10.1371/journal.pone.0117119
Christensen, M. S., Vestergaard, J. M., d'Amore, F., Gørløv, J. S.
, Toft, G., Ramlau-Hansen, C. H., Stokholm, Z. A., Iversen, I. B., Nissen, M. S. & Kolstad, H. A. (2018).
Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers.
Epidemiology,
29(3), 342-351.
https://doi.org/10.1097/EDE.0000000000000819
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M., Nijland, M., Diepstra, A., van den Berg, A.
, Kamper, P., d'Amore, F., d'Amore, A. L., Hamilton-Dutoit, S., Savage, K. J., Shah, S. P., Connors, J. M., Gascoyne, R. D., Scott, D. W. & Steidl, C. (2017).
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
Journal of Clinical Oncology,
35(32), 3722-3733.
https://doi.org/10.1200/JCO.2017.72.7925Cederleuf, H.
, Bjerregård Pedersen, M., Jerkeman, M., Relander, T.
, d'Amore, F. & Ellin, F. (2017).
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
British Journal of Haematology,
178(5), 739-746.
https://doi.org/10.1111/bjh.14740Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A. L., Fend, F., Friedberg, J. W., Gaulard, P., Ghia, P., Horwitz, S. M., King, R. L., Salles, G. ... Zelenetz, A. D. (2022).
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood,
140(11), 1229-1253.
https://doi.org/10.1182/blood.2022015851Bro, M. L., Johansen, C.
, Vuust, P., Enggaard, L., Himmelstrup, B., Mourits-Andersen, T., Brown, P.
, d'Amore, F., Andersen, E. A. W., Abildgaard, N. & Gram, J. (2019).
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
27(10), 3887-3896.
https://doi.org/10.1007/s00520-019-04666-8Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J.
, Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M. ... Chan, W. C. (2017).
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
Leukemia,
31(1), 83-91.
https://doi.org/10.1038/leu.2016.175Bencardino, M.
, D'Amore, F., Angot, H., Angiuli, L., Bertrand, Y., Cairns, W., Diéguez, M. C., Dommergue, A., Ebinghaus, R., Esposito, G., Komínková, K., Labuschagne, C., Mannarino, V., Martin, L., Martino, M., Neves, L. M., Mashyanov, N., Magand, O., Nelson, P. ... Pirrone, N. (2024).
Patterns and trends of atmospheric mercury in the GMOS network: Insights based on a decade of measurements.
Environmental Pollution,
363(Pt 2), Article 125104.
https://doi.org/10.1016/j.envpol.2024.125104Beck Enemark, M., Monrad, I., Madsen, C., Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C., Lauridsen, K. L., Plesner, T. L., Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Bech, M. R.
, Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & d'Amore, F. (2013).
Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
British Journal of Dermatology,
169(2), 469-72.
https://doi.org/10.1111/bjd.12324Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E.
, Hjorthaug, K., Viney, Z. N., Pike, L. C., Federico, M., Luminari, S., Radford, J., Trotman, J., Fosså, A., Berkahn, L., Molin, D.
, D'Amore, F., Sinclair, D. A. ... Johnson, P. W. (2016).
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
Blood,
127(12), 1531-1538.
https://doi.org/10.1182/blood-2015-11-679407Barrenetxea Lekue, C., Grasso Cicala, S., Leppä, S., Stauffer Larsen, T., Herráez Rodríguez, S., Alonso Caballero, C.
, Jørgensen, J. M., Toldbod, H., Leal Martínez, I.
& D’Amore, F. (2019).
Pixantrone beyond monotherapy: a review.
Annals of Hematology,
98(9), 2025-2033.
https://doi.org/10.1007/s00277-019-03749-0Antiga, E.
, Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A.
, D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. ... Marzano, A. V. (2023).
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology & Venereology,
37(6), 1118-1134.
https://doi.org/10.1111/jdv.18931Andersen, MP.
, Kamper, P., Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S. J., D'Amore, F. A. & Clausen, MR. (2013).
The number of tumour-infiltrating mast cells correlates with adverse prognosis in mixed cellularity, but not nodular sclerosis type, classical Hodgkin lymphoma.
Haematologica.
Andersen, R. K., Hammer, K., Hager, H., Christensen, J. N., Ludvigsen, M., Honoré, B., Thomsen, M.-B. & Madsen, M. (2015).
Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates. Pigment Cell & Melanoma Research.
https://doi.org/10.1111/pcmr.12352
Andersen, M. D.
, Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S., Clausen, M. & d'Amore, F. (2015).
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
European Journal of Haematology, 252-259.
https://doi.org/10.1111/ejh.12583Andersen, M. N., Ludvigsen, M., Abildgaard, N., Petruskevicius, I., Hjortebjerg, R., Bjerre, M., Honoré, B., Møller, H. J. & Andersen, N. F. (2017).
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.
OncoTargets and Therapy,
10, 1977-1982.
https://doi.org/10.2147/OTT.S124321
Andersen, M. D.
, Kamper, P., d’Amore, A.
, Clausen, M., Bentzen, H. & d'Amore, F. (2019).
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor†.
Leukemia & Lymphoma,
60(4), 927-933.
https://doi.org/10.1080/10428194.2018.1515939Andersen, M. I. D., Hamilton-Dutoit, S., Modvig, L.
, Vase, M., Christiansen, I., Christensen, J. H., Dahl-Sørensen, R. B., Stoltenberg, D.
, Kamper, P. & d'Amore, F. (2022).
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma: A study from the Danish Lymphoma Registry.
British Journal of Haematology,
198(1), 50-61.
https://doi.org/10.1111/bjh.18180
Andersen, M. D., Wolter, K., Enemark, M. B. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025).
Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement.
European Journal of Haematology, Supplement,
114(1), 173-185.
https://doi.org/10.1111/ejh.14326
Andersen, M. D., Wolter, K., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025).
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.
Leukemia & Lymphoma,
66(4), 656-667.
https://doi.org/10.1080/10428194.2024.2434170
Andersen, M. D., Wolter, K., Enemark, M. H.
, Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M. & Kamper, P. (2025).
Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma.
Journal of Pathology: Clinical Research,
11(4), Article e70038.
https://doi.org/10.1002/2056-4538.70038
Andersen, M. D., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M. & Kamper, P. (2025).
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.
Scientific Reports,
15(1), Article 30273.
https://doi.org/10.1038/s41598-025-16218-8
Amador, C., Greiner, T. C., Heavican, T. B., Smith, L. M., Galvis, K. T., Lone, W. G., Bouska, A.
, D'amore, F., Bjerregård Pedersen, M., Pileri, S. A., Agostinelli, C., Feldman, A. L., Rosenwald, A., Ott, G., Mottok, A., Savage, K. J., de Leval, L., Gaulard, P., Lim, S. T. ... Lymphoma/Leukemia Molecular Profiling Project (2019).
Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.
Blood,
134(24), 2159-2170.
https://doi.org/10.1182/blood.2019000779Agostinelli, C., Gallamini, A., Rigacci, L., Vitolo, U., Stracqualursi, L., Piccaluga, P., Stelitano, C., Patti, C., Argani, L., Broccoli, A., Levis, A.
, D'Amore, F. A., Zinzani, P. & Pileri, SA. (2011).
The prognostic value of biologic markers in classical Hodgkin Lymphoma (CHL) patients.
Annals of Oncology,
22(4), 206.
Agostinelli, C., Gallamini, A., Stracqualursi, L., Agati, P., Tripodo, C., Fuligni, F., Sista, M. T., Fanti, S., Biggi, A., Vitolo, U., Rigacci, L., Merli, F., Patti, C., Romano, A., Levis, A., Trentin, L., Stelitano, C., Borra, A., Piccaluga, P. P. ... Pileri, S. A. (2016).
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
The Lancet Haematology,
3(10), e467-e479.
https://doi.org/10.1016/S2352-3026(16)30108-9Abrahamsson, A., Albertsson-Lindblad, A., Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M.
, D'Amore, F., Nilsson-Ehle, H.
, Jensen, P., Pedersen, M., Geisler, C. H. & Jerkeman, M. (2014).
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood,
124(8), 1288-95.
https://doi.org/10.1182/blood-2014-03-559930